CRL

Charles River Laboratories (CRL)

Charles River Laboratories International Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:CRL

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/17	21 : 00	Business Wire	Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research	NYSE:CRL	Charles River Laboratories International Inc
2024/09/04	22 : 21	PR Newswire (US)	Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience	NYSE:CRL	Charles River Laboratories International Inc
2024/09/04	21 : 00	Business Wire	Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience	NYSE:CRL	Charles River Laboratories International Inc
2024/09/04	05 : 30	Business Wire	Charles River Laboratories to Present at Baird and Morgan Stanley Conferences	NYSE:CRL	Charles River Laboratories International Inc
2024/08/14	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/08/13	05 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/08/09	02 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/08/07	22 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:CRL	Charles River Laboratories International Inc
2024/08/07	20 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:CRL	Charles River Laboratories International Inc
2024/08/07	20 : 00	Business Wire	Charles River Laboratories Announces Second-Quarter 2024 Results	NYSE:CRL	Charles River Laboratories International Inc
2024/08/06	05 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/08/02	05 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/07/30	21 : 00	Business Wire	Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development	NYSE:CRL	Charles River Laboratories International Inc
2024/07/24	21 : 00	Business Wire	Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery	NYSE:CRL	Charles River Laboratories International Inc
2024/07/17	05 : 30	Business Wire	Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call	NYSE:CRL	Charles River Laboratories International Inc
2024/07/08	21 : 00	Business Wire	Charles River to Perform Plasmid Manufacturing for AAVantgarde	NYSE:CRL	Charles River Laboratories International Inc
2024/06/25	21 : 00	Business Wire	Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus	NYSE:CRL	Charles River Laboratories International Inc
2024/06/17	21 : 00	Business Wire	Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy	NYSE:CRL	Charles River Laboratories International Inc
2024/06/11	21 : 00	Business Wire	Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives	NYSE:CRL	Charles River Laboratories International Inc
2024/06/06	21 : 00	Business Wire	Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	NYSE:CRL	Charles River Laboratories International Inc
2024/06/05	05 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/06/05	05 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/06/05	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/06/05	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/06/05	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/06/05	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/06/04	21 : 00	Business Wire	Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research	NYSE:CRL	Charles River Laboratories International Inc
2024/06/04	05 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc
2024/06/03	21 : 00	Business Wire	Charles River Laboratories to Present at William Blair and Jefferies Conferences	NYSE:CRL	Charles River Laboratories International Inc
2024/06/01	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRL	Charles River Laboratories International Inc